43 / 64
REUNIÓN 4
35
Bibliografía
1. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al;
ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with
atrial fibrillation. N Engl J Med. 2011;365:981-92.
2. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al; ROCKET AF
Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J
Med. 2011;365:883-91.
3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al; RE-LY
Steering Committee and Investigators. Dabigatran versus warfarin in patients with
atrial fibrillation. N Engl J Med. 2009;361:1139-51.
4. Holster IL, Hunfeld NG, Kuipers EJ, Kruip MJ, Tjwa ET. On the treatment of new oral
anticoagulant-associated gastrointestinal hemorrhage. J Gastrointestin Liver Dis.
2013;22:229-31.
5. Zhou W, Schwarting S, Illanes S, Liesz A, Middelhoff M, Zorn M, et al. Hemostatic
therapy in experimental intracerebral hemorrhage associated with the direct thrombin
inhibitor dabigatran. Stroke. 2011;42:3594-9.
6. Peacock WF, Gearhart MM, Mills RM. Emergency management of bleeding associated
with old and new oral anticoagulants. Clin Cardiol. 2012;35:12:730-7.
7. Southworth MR, Reichman ME, Unger EF. Dabigatran and postmarketing reports of
bleeding. N Engl J Med. 2013;368:1272-4.
8. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Clinical
classification schemes for predicting hemorrhage: results from the National Registry
of Atrial Fibrillation (NRAF). Am Jeart J. 2006;151:713-9.
9. Pisters R, Lane DA, Nieuwlaat R, De Vos CB, Crijns HJ, Lip GY. A novel user-friendly
score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial
fibrillation: the Euro Heart Survey. Chest. 2010;138:1093-100.
10. Baglin T, Hillarp A, Tripodi A, Elalamy I, Buller H, Ageno W. Measuring oral direct
inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee
on Control of Anticoagulation of the Scientific and Standardization Committee of
the International Society on Thrombosis and Haemostasis. J Thromb Haemost.
2013;11:756-60.